Alzheimer's disease: An alternative approach.

Area of Science:

• Neurodegenerative diseases
• Dementia research
• Neurology

Background:

• Alzheimer's disease (AD) is the most prevalent neurodegenerative dementia, primarily affecting individuals over 65, with a higher incidence in females.
• AD prevalence is expected to increase significantly, affecting approximately 1 in 10 individuals over 65 by 2050.
• While most AD cases are sporadic, a small percentage follows an autosomal dominant inheritance pattern.

Purpose of the Study:

• To critically evaluate the current state of dementia research, focusing on Alzheimer's disease.
• To identify pitfalls in diagnosis, clinical features, pathogenesis, progression assessment, biomarkers, treatment, and prevention strategies for AD.
• To present preliminary findings on cost-effective methods for differentiating Alzheimer's disease from frontotemporal dementia.

Main Methods:

• Review of existing literature on Alzheimer's disease and dementia.
• Analysis of postulated pathomechanisms, including the amyloid cascade hypothesis and signal transducer and activation of transcription 3 (STAT3) pathway.
• Experimental investigation into inexpensive methods for differential diagnosis of dementia types.

Main Results:

• Established pathomechanisms for AD include amyloid precursor protein mutations leading to Aβ aggregation and STAT3-mediated signaling aberrations.
• Key pathological hallmarks of AD are senile plaques and neurofibrillary tangles.
• The study introduces novel approaches for distinguishing Alzheimer's disease from frontotemporal dementia.

Conclusions:

• Despite extensive research, dementia studies have not met global expectations, highlighting the need for improved diagnostic and therapeutic strategies.
• Understanding the complex pathomechanisms and pathological changes is crucial for effective AD management.
• The proposed inexpensive methods offer a promising avenue for accurate differential diagnosis in clinical settings.